ArticleCancer medicine2024

The Potential Therapeutic Targets of Anlotinib in Osteosarcoma: Characterization Based on Patient-Derived Xenografts and Next-Generation Sequencing.

Zuoyao Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.